Search by Drug Name or NDC
NDC 54092-0063-01 Agrylin 0.5 mg/1 Details
Agrylin 0.5 mg/1
Agrylin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is ANAGRELIDE HYDROCHLORIDE ANHYDROUS.
MedlinePlus Drug Summary
Anagrelide is used to decrease the number of platelets (a type of blood cell that is needed to control bleeding) in the blood of patients who have a bone marrow disorder, in which the body makes too many of one or more types of blood cells, such as essential thrombocythemia (condition in which the body makes too many platelets) or polycythemia vera (condition in which the body makes too many red blood cells and sometimes too many platelets). Anagrelide is in a class of medications called platelet-reducing agents. It works by slowing the production of platelets in the body.
Related Packages: 54092-0063-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Anagrelide
Product Information
| NDC | 54092-0063 |
|---|---|
| Product ID | 54092-063_40de069d-9fb0-4ad2-946d-babdbe02bf18 |
| Associated GPIs | 85156010100120 |
| GCN Sequence Number | 030949 |
| GCN Sequence Number Description | anagrelide HCl CAPSULE 0.5 MG ORAL |
| HIC3 | N1D |
| HIC3 Description | PLATELET REDUCING AGENTS |
| GCN | 22391 |
| HICL Sequence Number | 012902 |
| HICL Sequence Number Description | ANAGRELIDE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Agrylin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | anagrelide hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | ANAGRELIDE HYDROCHLORIDE ANHYDROUS |
| Labeler Name | Takeda Pharmaceuticals America, Inc. |
| Pharmaceutical Class | Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020333 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 54092-0063-01 (54092006301)
| NDC Package Code | 54092-063-01 |
|---|---|
| Billing NDC | 54092006301 |
| Package | 100 CAPSULE in 1 BOTTLE (54092-063-01) |
| Marketing Start Date | 1997-03-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |